Michal Kulich
Overview
Explore the profile of Michal Kulich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
824
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fogel J, Piwowar-Manning E, Donohue K, Cummings V, Marzinke M, Clarke W, et al.
J Acquir Immune Defic Syndr
. 2015 Apr;
69(4):430-8.
PMID: 25835607
Background: In resource-limited settings, HIV infection is often diagnosed using 2 rapid tests. If the results are discordant, a third tie-breaker test is often used to determine HIV status. This...
12.
Piwowar-Manning E, Fogel J, Richardson P, Wolf S, Clarke W, Marzinke M, et al.
J Clin Virol
. 2014 Dec;
62:75-9.
PMID: 25542477
Background: Fourth-generation HIV assays detect both antigen and antibody, facilitating detection of acute/early HIV infection. The Bio-Rad GS HIV Combo Ag/Ab assay (Bio-Rad Combo) is an enzyme immunoassay that simultaneously...
13.
Coates T, Kulich M, Celentano D, Zelaya C, Chariyalertsak S, Chingono A, et al.
Lancet Glob Health
. 2014 Aug;
2(5):e267-77.
PMID: 25103167
Background: Although several interventions have shown reduced HIV incidence in clinical trials, the community-level effect of effective interventions on the epidemic when scaled up is unknown. We investigated whether a...
14.
Laeyendecker O, Kulich M, Donnell D, Komarek A, Omelka M, Mullis C, et al.
PLoS One
. 2013 Nov;
8(11):e78818.
PMID: 24236054
Background: Accurate methods of HIV incidence determination are critically needed to monitor the epidemic and determine the population level impact of prevention trials. One such trial, Project Accept, a Phase...
15.
Pruhova S, Dusatkova P, Kraml P, Kulich M, Prochazkova Z, Broz J, et al.
Int J Endocrinol
. 2013 Oct;
2013:718254.
PMID: 24101925
Aim. GCK-MODY is an autosomal dominant form of diabetes caused by heterozygous mutations in the glucokinase gene leading to a lifelong mild hyperglycemia. The risk of macrovascular complications is considered...
16.
Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, et al.
PLoS One
. 2013 Jul;
8(7):e68349.
PMID: 23874597
Background: National Institute of Mental Health Project Accept (HIV Prevention Trials Network [HPTN] 043) is a large, Phase III, community-randomized, HIV prevention trial conducted in 48 matched communities in Africa...
17.
Kevany S, Murima O, Singh B, Hlubinka D, Kulich M, Morin S, et al.
J Public Health Afr
. 2012 Sep;
3(1):46-51.
PMID: 22962629
Zimbabwe's HIV epidemic is amongst the worst in the world, and disproportionately effects poorer rural areas. Access to almost all health services in Zimbabwe includes some form of cost to...
18.
Cinek O, Kulich M, Sumnik Z
Pediatr Diabetes
. 2012 Apr;
13(7):559-63.
PMID: 22487027
Aims: The aim was to assess trends in incidence of pediatric type 1 diabetes (T1D) using data recorded by the population-based Czech Childhood Diabetes Register over 1989-2009. Methods: New cases...
19.
Piwowar-Manning E, Fiamma A, Laeyendecker O, Kulich M, Donnell D, Szekeres G, et al.
BMC Infect Dis
. 2011 Sep;
11:251.
PMID: 21943026
Background: Project Accept is a community randomized, controlled trial to evaluate the efficacy of community mobilization, mobile testing, same-day results, and post-test support for the prevention of HIV infection in...
20.
Treggiari M, Retsch-Bogart G, Mayer-Hamblett N, Khan U, Kulich M, Kronmal R, et al.
Arch Pediatr Adolesc Med
. 2011 Sep;
165(9):847-56.
PMID: 21893650
Objective: To investigate the efficacy and safety of 4 antipseudomonal treatments in children with cystic fibrosis with recently acquired Pseudomonas aeruginosa infection. Design: Randomized controlled trial. Setting: Multicenter trial in...